Balance Sheet Data

Supernus Pharmaceuticals, Inc. (SUPN)

$34.93

-1.06 (-2.95%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 356.02347.07422.53339.68461.33583.51663.81755.16859.08977.31
Total Cash (%)
Account Receivables 102.9287.33140.88148.93165.50189.72215.83245.53279.32317.76
Account Receivables (%)
Inventories 25.6626.6348.3385.9691.5477.2587.8899.98113.74129.39
Inventories (%)
Accounts Payable 3.1910.146.159.3396.3431.2635.5640.4646.0352.36
Accounts Payable (%)
Capital Expenditure -0.84-2.74-3.45-2.04-0.41-3.01-3.42-3.89-4.43-5.04
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.